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Novelty & Impact:  Incidence in esophageal adenocarcinoma has increased sharply 
among all age groups; however one disconcerting trend is the increasing proportion of 
advanced-stage tumors occurring at younger (< 50 years) as opposed to older ages. 
The relative rarity of these malignancies has precluded prior studies from assessing risk 
factors across age groups. Pooling data from 8 case-control studies we found that 
recurrent heartburn/regurgitation and obesity were appreciably stronger risk factors for 
early-onset EA relative to older age-categories. 
 
Abbreviations: EA, esophageal adenocarcinoma; EGJA, esophagogastric junction 
adenocarcinoma; BMI, body mass index; NSAIDs, non-steroidal anti-inflammatory 
drugs; OR, odds ratio; CI, confidence interval. 
Keywords (MeSH terms): risk factors; esophageal cancer; case-control studies; 
obesity; age of onset 
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Abstract 
Esophageal (EA) and esophagogastric junction (EGJA) adenocarcinoma have been 
steadily increasing in frequency in younger people, however the etiology of these 
cancers is poorly understood. We therefore investigated associations of body- mass 
index (BMI), cigarette smoking, alcohol consumption, gastroesophageal reflux, and use 
of non-steroidal anti-inflammatory drugs (NSAIDs) in relation to age-specific risks of EA 
and EGJA. We pooled individual participant data from eight population-based, case-
control studies within the international Barrett’s and Esophageal Adenocarcinoma 
Consortium (BEACON). The analysis included 1,363 EA patients, 1,472 EGJA patients, 
and 5,728 control participants. Multivariable logistic regression was used to estimate 
odds ratios (ORs) and 95% confidence intervals (CIs) for age-specific (<50, 50–59, 60–
69, ≥70 years) cancer outcomes, as well as interactions by age. BMI, smoking status 
and pack-years, recurrent gastroesophageal reflux, and frequency of gastroesophageal 
reflux were positively associated with EA and EGJA in each age group. Early-onset EA 
(<50 years) had stronger associations with recurrent gastroesophageal reflux (OR=8.06, 
95%CI: 4.52, 14.37; Peffect modification=0.01) and BMI (ORBMI ≥30 vs. <25=4.19, 95%CI: 2.23, 
7.87; Peffect modification=0.04), relative to older age groups. In contrast, inverse associations 
of NSAID use were strongest in the oldest age group (≥70 years), although this 
apparent difference was not statistically significant. Age-specific associations with EGJA 
showed similar, but slightly weaker patterns and no statistically significant differences by 
age were observed. Our study provides evidence that associations between obesity and 
gastroesophageal reflux are stronger among earlier onset EA cancers.  
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Introduction 
Incidence of esophageal adenocarcinoma (EA) and esophagogastric junction 
adenocarcinoma (EGJA) has increased sharply in Western populations 1, 2 among all 
age groups 3-5. Survival has remained particularly poor, with five-year survival less than 
20% 6. A particularly disconcerting aspect is the growing proportion of advanced-stage 
tumors that occur at early-onset (< 50 years), as opposed to later-onset 7-9, with most 
recent estimates from SEER indicating approximately 8.2% of EAs/EGJAs are 
diagnosed in US individuals less than 50 years of age. Understanding whether and how 
risk factor profiles vary by age could provide evidence-based information that may 
inform clinical practice, as well as provide etiologic insight. 
A number of risk factors for EA and EGJA have been identified—irrespective of age at 
diagnosis.  Increased risk is associated with male sex, white race, hiatal hernia 10-12, 
gastroesophageal reflux 10, 13, obesity 14, and cigarette smoking 15, 16. Inverse 
associations with usage of nonsteroidal anti-inflammatory drugs (NSAIDs) 17 and 
moderate alcohol consumption 18 have also been observed. Few studies have 
conducted age-specific risk factor analyses for EA and EGJA. One study suggested that 
obesity is more strongly associated with risk of EA among younger patients (<50 years) 
19 while another reported that obesity among patients was associated with younger 
median age at diagnosis 20. Given the relative rarity of these malignancies prior studies 
have been limited in size, which has precluded detailed investigations across multiple 
age groups. Therefore, we leveraged the large sample size in the international Barrett’s 
and Esophageal Adenocarcinoma Consortium (BEACON) and comprehensively 
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evaluated risk factors by age at diagnosis, particularly focusing on early-onset (<50 
years) disease. 
Methods 
Study Population 
The BEACON consortium was formed in 2005 by an international group of investigators 
21-33. Consortium data consist of population-based case-control and cohort studies of 
EA, EGJA and Barrett’s esophagus.  The large total amount of consortium data enable 
the conduct of etiological studies of these conditions with excellent statistical power.  
For this analysis, we included eight case-control studies that provided data from both 
EA and EGJA patients: the nationwide Australian Cancer Study (esophageal cancer 
component) 32, Factors Influencing the Barrett’s Adenocarcinoma Relationship 
(FINBAR) Study 21, nationwide Swedish Esophageal and Cardia Center Study (SECC) 
28, Larynx/Esophagus/Oral cavity (LEO) Study 29, Los Angeles County Multi-ethnic 
Study 33, Nebraska Health Study II 31, Population Health Study 22, and the United States 
(US) Multi–Center Study 27. Details about source populations, case definitions, 
recruitment procedures, participants, and study designs have been reported previously 
21-34.  
The main outcomes of interest were age-specific groups of EA and EGJA patients; 
particularly early-onset disease (<50 years) given that risk factor profiles for this rarer 
group are poorly understood. Subjects were limited to those of white non-Hispanic 
ancestry, because of relatively small numbers of non-white or Hispanic patients (26 
black, 89 Hispanic, 42 other race or ethnic groups). The eight studies together provided 
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2,835 patients (1,363 EA, 1,472 EGJA) and 5,728 controls for analysis. Data acquisition 
and data pooling were approved by the Institutional Review Board or Research Ethics 
Committee of each participating institution included in the study.  
Study Variables 
Included studies provided information on age at diagnosis for case patients, age at 
interview for controls, sex, education, usual adult body mass index (BMI: weight divided 
by square of height [kg/m2]), alcohol consumption, cigarette smoking, and study center 
(for multi-center studies). Studies or their subsets also included information on reported 
heartburn and regurgitation 21, 27, 28, 32, 33, and NSAID usage 21, 27, 32, 33. Detailed 
information on exposure harmonization and detailed analyses of these risk factors has 
been reported previously for BMI 14, alcohol consumption 18, cigarette smoking 16, 34, 
heartburn/regurgitation 15, and NSAIDs use 17. The categories for age at diagnosis were 
selected a priori based on convenient cut-points (<50, 50–59, 60–69, ≥70 years) for 
ease of interpretation. 
Statistical Analysis 
Primary exposure variables of interest included BMI, alcohol consumption, cigarette 
smoking, heartburn and regurgitation, and NSAID usage. Because of the small number 
of early-onset esophageal cancer diagnoses in each study (Table 1), we pooled data for 
our analysis, rather than using a 2-step meta-analytic approach as in most prior 
BEACON studies that have focused on a single exposure in relation to cancer 
diagnosed at any age and include larger case groups, such as BMI 14, alcohol 18, 
smoking 34, or gastroesophageal reflux 15. Multivariable logistic regression models were 
used to estimate odds ratios (ORs) and their 95% confidence intervals (CIs) for the 
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association between each primary exposure variable and each outcome (EA or EGJA) 
stratified by age (diagnosis for cases, interview for controls; <50, 50–59, 60–69, ≥70 
years). Covariates included in the multivariable logistic regression models (if not 
assessed as primary exposure variables) included age (continuous), sex, study, study-
center (for multicenter studies), education (< or ≥ high school), BMI (continuous), ever 
regular consumption of alcohol, and smoking status (never, current, former), as these 
variables are either of primary interest or known to be associated with these 
malignancies and thus potential confounders 35. 
As previously noted, a subset of studies also included information on the following risk 
factors: heartburn, regurgitation or both as recurrent symptoms (≥ weekly frequency: 
yes/no) and frequency of heartburn, regurgitation or both (never, <monthly, monthly to 
<weekly, weekly to <daily, ≥daily) and regular NSAID use (ever/never; including aspirin 
usage and non-aspirin NSAID usage). 
To assess effect modification by age group, we used the likelihood-ratio statistic to 
compare nested models of the age-adjusted main-effect data (i.e., not stratified by age) 
with a model that also included main-effect exposure-age category interaction terms 
(<50, 50–59, 60–69, ≥70 years; 3df). All analyses were performed using Stata software 
version 13. All statistical tests were two–sided and P-values less than 0.05 were 
considered to be statistically significant.  
Results 
In total, data from 1,363 EA and 1,472 EGJA case patients were available for the 
analysis (Table 1). Among these subjects, 125 EA and 174 EGJA patients had been 
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diagnosed at <50 years of age (10.5%), 314 EA and 334 EGJA diagnosed at 50–59 
years of age (22.9%), 473 EA and 526 EGJA diagnosed at 60–69 years of age (35.2%), 
and 451 EA and 438 EGJA patients diagnosed at ≥70 years of age (31.4%). In total, 
5,728 population controls—including 790 aged <50 years, 1,286 aged 50–59 years, 
1,936 aged 60–69 years, and 1,716 aged ≥70 years—were available for comparison 
(Table 1). Study participant characteristics by age at diagnosis/interview are shown in 
Supplementary Table 1. 
The overall and age-specific risk factor profiles of EA and EGJA are provided in Tables 
2 and 3. Overall we observed an increased risk of EA and EGJA with increasing BMI, 
whereas alcohol consumption categories up to 3–5 drinks per day, but not more, were 
inversely associated, each compared with the 0 drinks per day category. Current or 
former cigarette smoking status were each positively associated with increased risk of 
both EA and EGJA, and we observed a trend of increasing risks with increasing 
cumulative exposure to tobacco smoke (pack-years). Recurrent heartburn and/or 
recurrent regurgitation, and greater frequency of symptoms were associated with 
increased risk of both cancers. Lastly, we observed inverse associations with use of 
NSAIDs and aspirin, and a modest inverse association with non-aspirin NSAID usage 
with EA. In contrast, associations between NSAID use and EGJA were mostly null. 
These results are similar to individual exposures investigated in prior BEACON studies 
14, 15, 17, 18, 34. 
We next evaluated age-specific associations of each exposure in relation to EA. Obesity 
(BMI ≥30) was most strongly associated with early-onset EA (OR=4.19, 95%CI: 2.23, 
7.87), with significant differences across age groups (Peffect modification=0.042). The 
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magnitude of the association was higher in early-onset EA than in later-onset patients. 
ORs for the other age categories ranged between 2.6–2.8. When we limited our 
analysis to studies including reflux variables and further adjusted models by recurrent 
reflux, little difference was seen in the association between BMI and EA in the youngest 
age group (Supplemental Table 3: OR: 2.1 vs OR: 2.3) and age remained an effect 
modifier (Peffect modification=0.002).  
Alcohol consumption and number of drinks per day showed little to no associations with 
risk of EA among age groups <50, 50–59, and 60–69 years. However, for the age group 
≥70 years the inverse association for regular drinking was stronger and gained nominal 
statistical significance (OR 0.62, 95%CI: 0.45, 0.85). Similar findings were found for 
frequency of alcohol consumption, up to and including the 5–<7 drinks per day category. 
However, tests for effect modification by age were not statistically significant for either 
ever regularly consuming alcohol (Peffect modification=0.17) or for frequency of alcohol 
consumption (Peffect modification=0.33). 
Current and former cigarette smokers were at increased risk of EA in each age group 
assessed compared with never-smokers. ORs ranged between 1.81 and 3.75 for former 
and current smokers. Effect modification by age was observed (P=0.028), yet no 
obvious linear pattern across age groups was seen. Associations were strongest for 50–
59 year olds and weakest for 60–69 year olds, and these differences persisted when 
pack-years of cigarette smoking was included in the model, albeit the P value for effect 
modification was slightly attenuated and not statistically significant (P=0.073).  
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We observed statistically significant positive associations between recurrent 
gastroesophageal reflux variables (≥ weekly symptoms) and EA risk for all age groups. 
The strongest associations were observed for early-onset EA, with ORs ranging from 
6.62 to 8.06 and age was consistently a significant effect modifier (Peffect modification=0.02–
0.04). In contrast, associations between EA and frequency of heartburn and/or 
regurgitation symptoms were similar across each age groups (Peffect modification=0.16–
0.57). 
Regular use of NSAIDs and aspirin were inversely associated with EA for the age group 
≥ 70 years. For all other age groups assessed, weaker inverse associations of these 
exposures with EA risk were seen, although most of them were not statistically 
significant and neither were their tests effect modifications by age (P=0.09–0.12). No 
substantial differences for regular use of non–aspirin NSAIDs were seen by age group 
and were not associated. 
Age-specific analyses of EGJA (Table 3) provided generally similar results to those 
observed for EA (Table 2). Age-specific associations of BMI, alcohol, and 
gastroesophageal reflux exposures in relation to EGJA were slightly attenuated when 
compared with those for EA, but were similar in patterns and direction. However, none 
of these apparent differences were statistically significant. Inverse associations were 
seen between users of non-aspirin NSAIDs and EGJA in older age groups (60–69 and ≥ 
70) compared with non-users. However, unlike the EA analysis, no associations were 
observed with regular usage of aspirin.  
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Discussion 
In this large pooled analysis of eight population-based case-control studies we found 
that recurrent heartburn/regurgitation and obesity were appreciably stronger risk factors 
for early-onset EA relative to older age categories. Conversely, low/moderate alcohol 
consumption and use of aspirin and NSAIDs were inversely associated with late-onset 
EA, although effect modifications of these associations by age were not significant. Age-
specific associations with EGJA showed similar, but slightly weaker patterns and no 
statistically significant differences by age were observed. 
To our knowledge this is the first pooled analysis aimed to evaluate and compare age-
specific risk factor profiles for EGJA and one of only a few for EA. In a prior study of 
age-specific risk factors of EA (cases: n=356), the authors also found that obesity was 
associated with a younger age at cancer diagnosis 20. Our pooled analysis corroborates 
that finding and provides detailed investigations of the major risk factors across multiple 
age groups. Although the rise in EA incidence predates the rise in obesity 36, it is still 
possible that obesity is implicated in more recent increases in EA incidence; as 
evidenced by the strong associations with BE and EA observed in prior BEACON 
analyses 37, 38 and other studies 39. 
The predominant mechanism by which central adiposity is proposed to increase risk of 
esophageal cancer is by disrupting the integrity of the lower esophageal sphincter; 
leading to increased propensity for gastroesophageal reflux 40. Independent of the 
“mechanical effect” of central adiposity on cancer risk, proinflammatory effects of 
excess adipose tissue may increase risk of EA via systemic proinflammatory effects 14, 
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40, 41. In this study we also observed some evidence for an effect of obesity on risk of EA 
that is independent of reflux symptoms. 
No prior study, independent of the studies contributing to this pooled analysis, has 
investigated age-specific associations between recurrent heartburn/regurgitation and 
risk of EA. Reflux increases secretion of numerous proinflammatory cytokines such as 
IL-6 and TNF-α and reactive oxygen species 42-44. As a recognized hallmark of cancer 
45, inflammation induced by reflux is likely to contribute substantially to the development 
and progression of esophageal adenocarcinoma 46. Among a subset of the EA patients 
included in this study, four SNPs in three apoptosis genes (BCL2, CASP8, and 
TNFRSF10A) were previously identified as significantly associated with early-onset EA 
(≤55 vs >55 years) 9. Taken together, one possible explanation for our results is that 
patients diagnosed with EA at younger ages may have increased likelihood of genetic 
susceptibility to the deleterious effect of reflux, perhaps having decreased ability to 
expunge damaged cells via apoptosis. This process could lead to the accumulation of 
oncogenic mutations in the esophageal cell population, heightening the risk of early-
onset EA.  
An important strength of our study was the availability of individual participant data from 
eight population-based, case-control studies, which provided sufficient case numbers 
required to identify risk factor profiles for early and late-onset disease and to assess 
effect modification by age. Our exposure variables are believed to have a high degree 
of reliability, since each was constructed using a unified approach across studies and 
each exposure in relation to EA and EGJA has been examined and published. Our 
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overall results corroborate the findings of these prior studies 14, 15, 17, 18, 34 and provide 
confidence in our statistical approach.  
However, several limitations of our analysis should be considered. We have not 
assessed heritability or genetic factors. These factors could induce differential residual 
confounding by age at diagnosis, possibly contributing to the effect modification by age 
effects that we observed 47-50. The categories for age at diagnosis were selected a priori 
based on convenient cut-points for ease of interpretation, however, similar trends were 
observed when age-at-diagnosis categories were based on quartiles of age among 
controls (data not shown). It is important to note that our analysis includes self-reported 
symptoms of heartburn and regurgitation, yet reflux exposures can occur without 
apparent symptoms. Symptoms have been shown to correlate with greater severity of 
acid reflux exposure 51; nonetheless our results may only apply to people with 
symptomatic heartburn or regurgitation.  
Overall, this study confirms that smoking, obesity, recurrent or frequent 
heartburn/regurgitation are all associated with increased risk of EA and EGJA across all 
ages studied. In addition, we found evidence that recurrent heartburn/regurgitation and 
obesity are more strongly associated with risk of early-onset EA, compared with older 
age groups. Understanding the mechanisms through which obesity and reflux confer 
increased risks of esophageal cancer at younger ages might yield important insights for 
prevention and control of this cancer. Moreover, as the clinical community aims to 
incorporate more evidence-based health decisions, it is prudent that age-specific risk 
estimates be considered. 
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